NSCLC: RWE-Daten zur Sequenztherapie
Oncol Res Treat 2022;45:382 –383 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - June 2, 2022 Category: Cancer & Oncology Source Type: research
Erstlinientherapie nicht-transplantationsf ähiger Myelom-Patient*innen mit D-Rd
Oncol Res Treat 2022;45:380 –381 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - June 2, 2022 Category: Cancer & Oncology Source Type: research
Established and experimental systemic treatment options for advanced liposarcoma
Background:
While soft tissue sarcomas (STSs) are rare tumors, liposarcomas are among the most common type of STS and are divided into four main subtypes: atypical lipomatous tumor/well-differentiated liposarcoma (ALT/WDLPS); dedifferentiated liposarcoma (DDLPS); myxoid/round cell liposarcoma (MLPS); and pleomorphic liposarcoma (PLPS). The four different subtypes of liposarcomas have varying underlying molecular pathology, clinical behavior, and treatment sensitivity.
Summary:
Surgical resection is the mainstay of treatment for patients with localized liposarcoma. Radiotherapy is often used in conjunction with surgery f...
Source: Oncology Research and Treatment - May 24, 2022 Category: Cancer & Oncology Source Type: research
Successful liver transplantation of recurrent fibrolamellar carcinoma following clinical and pathologic complete response to triple immunochemotherapy: A case report.
Conclusion: For patients with unresectable/recurrent FLC with no distant disease, the combination of 5-FU, IFN alfa-2b, and nivolumab could be an effective systemic therapy option. The use of this chemoimmunotherapy regimen to downstage FLC prior to OLT may be worth investigating further. (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 10, 2022 Category: Cancer & Oncology Source Type: research
Abdominal wall reconstruction using Omental Flap with Mesh repair following resection of Aggressive Abdominal Wall Neoplasms
Conclusion: Immediate use of omental flap with synthetic (PP) mesh for recon struction of abdominal wall defects is a feasible technique and has avoided the complications associated with the use of synthetic mesh alone. (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 10, 2022 Category: Cancer & Oncology Source Type: research
A case report on cannabinoid hyperemesis syndrome in palliative care: how good intentions can go wrong
Conclusion: Successful recognition and management of cannabinoid hyperemesis syndrome is especially important in individuals with co-morbid disorders in order to avoid cannabis toxicity. (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 3, 2022 Category: Cancer & Oncology Source Type: research
Society Bulletins
Oncol Res Treat 2022;45:313 –318 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 2, 2022 Category: Cancer & Oncology Source Type: research
PharmaNews
Oncol Res Treat 2022;45:307 –312 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 2, 2022 Category: Cancer & Oncology Source Type: research
PharmaNews
Oncol Res Treat 2022;45:304 –306 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 2, 2022 Category: Cancer & Oncology Source Type: research
Chancen tumoragnostischer Therapieans ätze
Oncol Res Treat 2022;45:302 –303 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 2, 2022 Category: Cancer & Oncology Source Type: research
Real-World-Evidenz best ätigt Effektivität von Inotuzumab Ozogamicin
Oncol Res Treat 2022;45:300 –301 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 2, 2022 Category: Cancer & Oncology Source Type: research
CTCL-Therapie mit Mogamulizumab
Oncol Res Treat 2022;45:299 –299 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 2, 2022 Category: Cancer & Oncology Source Type: research
OnkoImmun 16
Oncol Res Treat 2022;45:I –XII (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - May 2, 2022 Category: Cancer & Oncology Source Type: research
Inflammatory Myofibroblastic Tumor in the Thyroid Gland: A Retrospective Case Series Study and Literature Review
Conclusion: IMT in the thyroid gland is a rare disease with a good prognosis and surgical resection is the preferred treatment. (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - April 11, 2022 Category: Cancer & Oncology Source Type: research
Society Bulletins
Oncol Res Treat 2022;45:234 –240 (Source: Oncology Research and Treatment)
Source: Oncology Research and Treatment - April 4, 2022 Category: Cancer & Oncology Source Type: research
